Multicenter trial of prolonged infusions of rocuronium bromide in critically III patients: Effects of multiple organ failure

Southern Medical Journal

Volumn 94, Issue 1, 2001, Pages 36-42

  Circeo, Lori E ^a   Reeves, Scott T ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT; ROCURONIUM;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DRUG MONITORING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLIC CLEARANCE RATE; METABOLISM; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PROSPECTIVE STUDY; TIME;

ADULT; ANDROSTANOLS; CRITICAL ILLNESS; DRUG MONITORING; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; TIME FACTORS;

EID: 0035220022     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200194010-00007     Document Type: Article

References (16)

1. Prielipp RC, Coursin DB, Scuderi PE, et al: Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesth Analg 1995; 81:3-12
2. Murray MJ, Coursin DB, Scuderi PE, et al: Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents. Crit Care Med 1995; 23:450-458
3. Khuenl-Brady KS, Reitstatter B, Schlager A, et al: Long-term administration of pancuronium and pipecuronium in the intensive care unit. Anesth Analg 1994; 78:1082-1086
4. Darrah WC, Johnston JR, Mirakhur RK: Vecuronium infusions for prolonged muscle relaxation in the intensive care unit. Crit Care Med 1989; 17:1297-1300
5. Sparr HJ, Wierda JM, Proost JH, et al: Pharmacodynamics and pharmacokinetics of rocuronium in intensive care patients. Br J Anaesth 1997; 78:267-273
6. Prielipp RC, Coursin DB: Applied pharmacology of common neuromuscular blocking agents in critical care. New Horizons 1994; 2:34-47
7. Reeves ST, Turcasso NM: Nondepolarizing neuromuscular blocking drugs in the intensive care unit: a clinical review. South Med J 1997; 90:769-774
8. Magorian T, Wood P, Caldwell J, et al: The pharmacokinetics and neuromuscular effects of rocuronium bromide in patients with liver disease. Anesth Analg 1995; 80:754-759
9. Khalil M, D'Honneur G, Duvaldestin P, et al: Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis. Anesthesiology 1994; 80:1241-1247
10. Servin FS, Lavaut E, Kleef U, et al: Repeated doses of rocuronium bromide administered to cirrhotic and control patients receiving isoflurane. a clinical and pharmacokinetic study. Anesthesiology 1996; 84:1092-1100
11. van Miert MM, Eastwood NB, Boyd AH, et al: The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis. Br J Clin Pharmacol 1997; 44:139-144
12. Khuenl-Brady KS, Pomaroli A, Puhringer F, et al: The use of rocuronium (ORG 9426) in patients with chronic renal failure. Anaesthesia 1993; 48:873-875
13. Szenohradszky J, Fisher DM, Segredo V, et al: Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. Anesthesiology 1992; 77:899-904
14. Cooper RA, Mirakhur RK, Wierda JM, et al: Pharmacokinetics of rocuronium bromide in patients with and without renal failure. Eur J Anaesthesiol Suppl 1995; 11:43-44
15. Schramm WM, Strasser K, Bartunek A, et al: Effects of rocuronium and vecuronium on intracranial pressure, mean arterial pressure and heart rate in neurosurgical patients. Br J Anaesth 1996; 77:607-611
16. Hudson ME, Rothfield KP, Tullock WC, et al: Haemodynamic effects of rocuronium in adult cardiac surgical patients. Can J Anaesth 1998; 45:139-143